130 related articles for article (PubMed ID: 2507878)
1. N-acetyl-L-tyrosine and N-acetyl-L-cysteine as tyrosine and cysteine precursors during intravenous infusion in humans.
Magnusson I; Ekman L; Wångdahl M; Wahren J
Metabolism; 1989 Oct; 38(10):957-61. PubMed ID: 2507878
[TBL] [Abstract][Full Text] [Related]
2. Amino acid solutions for premature neonates during the first week of life: the role of N-acetyl-L-cysteine and N-acetyl-L-tyrosine.
Van Goudoever JB; Sulkers EJ; Timmerman M; Huijmans JG; Langer K; Carnielli VP; Sauer PJ
JPEN J Parenter Enteral Nutr; 1994; 18(5):404-8. PubMed ID: 7815670
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of the cysteine-S-conjugate and mercapturic acid of tetrafluoroethylene to acylating reactive intermediates in the rat: dependence of activation and deactivation activities on acetyl coenzyme A availability.
Commandeur JN; De Kanter FJ; Vermeulen NP
Mol Pharmacol; 1989 Oct; 36(4):654-63. PubMed ID: 2811861
[TBL] [Abstract][Full Text] [Related]
4. Utilization of methionine and N-acetyl-L-cysteine during long-term parenteral nutrition in the growing rat.
Neuhäuser M; Grötz KA; Wandira JA; Bässler KH; Langer K
Metabolism; 1986 Sep; 35(9):869-73. PubMed ID: 3091992
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine is a highly available precursor for cysteine in the neonatal piglet receiving parenteral nutrition.
Shoveller AK; Brunton JA; Brand O; Pencharz PB; Ball RO
JPEN J Parenter Enteral Nutr; 2006; 30(2):133-42. PubMed ID: 16517958
[TBL] [Abstract][Full Text] [Related]
6. N -Acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion.
Ventura P; Panini R; Pasini MC; Scarpetta G; Salvioli G
Pharmacol Res; 1999 Oct; 40(4):345-50. PubMed ID: 10527647
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of L-cysteine S-conjugates and N-(trideuteroacetyl)-L-cysteine S-conjugates of four fluoroethylenes in the rat. Role of balance of deacetylation and acetylation in relation to the nephrotoxicity of mercapturic acids.
Commandeur JN; Stijntjes GJ; Wijngaard J; Vermeulen NP
Biochem Pharmacol; 1991 Jun; 42(1):31-8. PubMed ID: 2069595
[TBL] [Abstract][Full Text] [Related]
8. The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine.
Banks MF; Stipanuk MH
J Nutr; 1994 Mar; 124(3):378-87. PubMed ID: 8120657
[TBL] [Abstract][Full Text] [Related]
9. Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine.
Dilger RN; Baker DH
J Anim Sci; 2007 Jul; 85(7):1712-8. PubMed ID: 17371789
[TBL] [Abstract][Full Text] [Related]
10. Utilization of intravenously administered N-acetyl-L-glutamine in humans.
Magnusson I; Kihlberg R; Alvestrand A; Wernerman J; Ekman L; Wahren J
Metabolism; 1989 Aug; 38(8 Suppl 1):82-8. PubMed ID: 2569664
[TBL] [Abstract][Full Text] [Related]
11. Formation of three N-acetyl-L-cysteine monoadducts and one diadduct by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with N-acetyl-L-cysteine at physiological conditions: chemical mechanisms and toxicological implications.
Barshteyn N; Elfarra AA
Chem Res Toxicol; 2007 Oct; 20(10):1563-9. PubMed ID: 17892265
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of N-acetylcysteine following repeated intravenous infusion in haemodialysed patients.
Soldini D; Zwahlen H; Gabutti L; Marzo A; Marone C
Eur J Clin Pharmacol; 2005 Feb; 60(12):859-64. PubMed ID: 15657783
[TBL] [Abstract][Full Text] [Related]
13. N-acetyl-L-tyrosine as a tyrosine source during total parenteral nutrition in adult rats.
Im HA; Meyer PD; Stegink LD
Pediatr Res; 1985 Jun; 19(6):514-8. PubMed ID: 3925425
[TBL] [Abstract][Full Text] [Related]
14. No net splanchnic release of glutathione in man during N-acetylcysteine infusion.
Poulsen HE; Vilstrup H; Almdal T; Dalhoff K
Scand J Gastroenterol; 1993 May; 28(5):408-12. PubMed ID: 8511501
[TBL] [Abstract][Full Text] [Related]
15. [Utilization of N-acetylated amino acids in solutions for intravenous feeding. Cleavage of N-acetyltyrosine and N-acetylcysteine in rat tissues].
Neuhäuser M; Welsch B; Bässler B
Z Ernahrungswiss; 1982 Mar; 21(1):21-6. PubMed ID: 6803462
[TBL] [Abstract][Full Text] [Related]
16. In vivo kinetic analysis of covalent binding between N-acetyl-L-cysteine and plasma protein through the formation of mixed disulfide in rats.
Harada D; Naito S; Hiraoka I; Otagiri M
Pharm Res; 2002 May; 19(5):615-20. PubMed ID: 12069163
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of N-acetyl-L-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability.
Sjödin K; Nilsson E; Hallberg A; Tunek A
Biochem Pharmacol; 1989 Nov; 38(22):3981-5. PubMed ID: 2597179
[TBL] [Abstract][Full Text] [Related]
18. Metabolism, excretion, and pharmacokinetics of S-allyl-L-cysteine in rats and dogs.
Amano H; Kazamori D; Itoh K; Kodera Y
Drug Metab Dispos; 2015 May; 43(5):749-55. PubMed ID: 25681129
[TBL] [Abstract][Full Text] [Related]
19. N-acetyl-L-tyrosine as a tyrosine source in adult parenteral nutrition.
Hoffer LJ; Sher K; Saboohi F; Bernier P; MacNamara EM; Rinzler D
JPEN J Parenter Enteral Nutr; 2003; 27(6):419-22. PubMed ID: 14621123
[TBL] [Abstract][Full Text] [Related]
20. Stability of
Sommer I; Schwebel H; Adamo V; Bonnabry P; Bouchoud L; Sadeghipour F
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32575864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
